 |
|
What Are the Needs for Transplantation Treatment in Vitiligo, and How Good Is It?
Arch Dermatol. 2004;140:1273-1274.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Patchy loss of skin pigmentation can have significant consequences for affected individuals, who often experience difficulty functioning as socially active individuals and may not achieve the lifestyle they desire simply because they have white spots on their skin. In some countries with a predominantly dark-skinned population, leukoderma (white skin) can result in social stigmatization, leading to major difficulties in getting married and obtaining work.1 I have worked in India on several occasions and observed some of the social problems that this type of skin disorder can cause. In addition, the white areas, which lack melanin pigmentation, are very sensitive to sun exposure; in the summer, affected individuals must wear protective clothing and sunscreens.
Several etiologically distinct disorders or unrelated side effects of different physical or chemical treatments result in leukoderma, but in most cases we do not understand the biological mechanisms that underlie these disorders.
The most common disorder that . . . [Full Text of this Article] SURGICAL THERAPIES: WHEN AND HOW?
SAFETY
Mats J. Olsson, PhD
RELATED ARTICLES
Double-blind Placebo-Controlled Study of Autologous Transplanted Epidermal Cell Suspensions for Repigmenting Vitiligo
Nanny van Geel, Katia Ongenae, Martine De Mil, Yves Vander Haeghen, Chris Vervaet, and Jean Marie Naeyaert
Arch Dermatol. 2004;140(10):1203-1208.
ABSTRACT
| FULL TEXT
Long-term Follow-up Study of Segmental and Focal Vitiligo Treated by Autologous, Noncultured Melanocyte-Keratinocyte Cell Transplantation
Sanjeev V. Mulekar
Arch Dermatol. 2004;140(10):1211-1215.
ABSTRACT
| FULL TEXT
|
